The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pereverzev A.P.

Russian Medical Academy of Continuing Professional Education

Pereverzeva A.S.

Peoples’ Friendship University of Russia

Popadyuk V.I.

Peoples’ Friendship University of Russian

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

Herpangina. Clinical case

Authors:

Pereverzev A.P., Pereverzeva A.S., Popadyuk V.I., Ostroumova O.D.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2021;86(5): 97‑102

Read: 17963 times


To cite this article:

Pereverzev AP, Pereverzeva AS, Popadyuk VI, Ostroumova OD. Herpangina. Clinical case. Russian Bulletin of Otorhinolaryngology. 2021;86(5):97‑102. (In Russ.)
https://doi.org/10.17116/otorino20218605197

Recommended articles:
Mela­noma of the maxi­llary sinus mucosa. Stomatology. 2025;(2):82-85
Febrile infe­ction-related epilepsy syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):34-40
A case of the vaso­spastic angina deve­lopment due to acute myocarditis in the patient. Russian Journal of Preventive Medi­cine. 2025;(8):102-109
A clinical case of treating a patient with severe ischemic stroke and cancer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):114-117
D4 duodenal injury: a case report and lite­rature review. Piro­gov Russian Journal of Surgery. 2025;(10):136-141

References:

  1. Enterovirusnye zabolevaniya: klinika, laboratornaya diagnostika, epidemiologiya, profilaktika: Metodicheskie ukazaniya. M.: Federal’nyj tsentr gigieny i epidemiologii Rospotrebnadzora; 2006. (In Russ.).
  2. WHO. A Guide to clinical management and public health response for hand, foot and mouth disease (HFMD). Accessed August 06, 2021. https://www.who.int/ru
  3. Kosherova BN, Shopaeva GA, Maukaeva SB, Yukhnevich EA. Proekt klinicheskogo protokola diagnostiki i lecheniya enterovirusnykh infektsij. 2017. (In Russ.). Accessed August 06, 2021. https://www.rcrz.kz/docs/clinic_protocol/tc/%D0%AD%D0%BD%D1%82%D0%B5%D1%80%D0%BE%D0%B2%D0%B8%D1%80%D1%83%D1%81%D0%BD%D0%B0%D1%8F%20%D0%B8%D0%BD%D1%84%D0%B5%D0%BA%D1%86%D0%B8%D1%8F.pdf
  4. Tsarkova SA, Moroz GA, Birulya NI. Assessment of the possibility of introducing an international protocol for the management of children with enteroviral vesicular stomatitis at the outpatient stage of pediatric care. Russkij meditsinskij zhurnal. 2018;26(9):17-19. (In Russ.).
  5. Corsino CB, Ali R, Linklater DR. Herpangina. [Updated 2021 May 07]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Accessed August 06, 2021. https://www.ncbi.nlm.nih.gov/books/NBK507792/
  6. Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, Gao F, Wu X, Ye Q, Li XL, Zhu FC, Liang Z. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. Human Vaccines & Immunotherapeutics. 2017;13(4):823-830.  https://doi.org/10.1080/21645515.2016.1236879
  7. Miyazawa I, Azegami Y, Kasuo S, Yoshida T, Kobayashi M, Shiraishi T. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007. Japanese Journal of Infectious Diseases. 2008;61(3):247-248. 
  8. Ceylan AN, Turel O, Gultepe BS, Inan E, Turkmen AV, Doymaz MZ. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul. Polish Journal of Microbiology. 2019;68(2):165-171.  https://doi.org/10.21307/pjm-2019-016
  9. Arkhipina SA, Grinishina EA. Clinical and epidemiological analysis of cases of enterovirus infection in the oryol region in adults. The Clinician. 2020;14(3-4):52-56. (In Russ.). https://doi.org/10.17650/1818-8338-2020-14-3-4-K616
  10. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) (official website). Accessed August 06, 2021. (In Russ.). https://icd.who.int/browse10/2019/en#/B00-B09
  11. Keawcharoen J. Hand, Foot, and Mouth Disease. The Thai Veterinary. Medicine. 2012;42(3):255-258. 
  12. Centers for Disease Control and Prevention, CDC. Accessed August 06, 2021. https://www.cdho.org/Advisories/CDHO_Factsheet_Herpangina.pdf
  13. Gompf SG, Casanas BC, Carrington M. Herpangina. Medscape. Updated: Jun 18, 2019. Accessed August 06, 2021. https://emedicine.medscape.com/article/218502-overview
  14. Fourie J, Boy SC. Oral mucosal ulceration — a clinician’s guide to diagnosis and treatment. The Journal of the Dental Association of South Africa. 2016;71(10):500-508. 
  15. Official website of the Irish Health Service Executive (HSE). Accessed August 06, 2021. https://www.hse.ie/eng/health/az/h/hand,-foot-and-mouth-disease/preventing-hand,-foot-and-mouth-disease.html
  16. Subspecialty Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association; National Center for Quality Control of Infectious Diseases. [Expert consensus on diagnosis and treatment of herpangina (version 2019)]. Zhonghua Er Ke Za Zhi. 2019;57(3):177-180.  https://doi.org/10.3760/cma.j.issn.0578-1310.2019.03.004
  17. Official website of the National Institute for Health and Care Excellence (NICE). Accessed August 06, 2021. https://www.evidence.nhs.uk/search?ps=30&q=sore+mouth
  18. Gosudarstvennyj reestr lekarstvennykh sredstv Minzdrava Rossii. (In Russ). Accessed August 06, 2021. https://grls.rosminzdrav.ru
  19. Sironi M, Milanese C, Vecchi A, Polenzani L, Guglielmotti A, Coletta I, Landolfi C, Soldo L, Mantovani A, Pinza M. Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. International Journal of Clinical and Laboratory Research. 1997;27(2):118-122.  https://doi.org/10.1007/bf02912445
  20. Modéer T, Yucel-Lindberg T. Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1 beta or tumor necrosis factor alpha. Acta Odontologica Scandinavica. 1999;57(1):40-45.  https://doi.org/10.1080/000163599429093
  21. Chernyshova OE. A rational approach to the treatment of acute tonsillopharyngitis in children. Zdorov’e rebenka. 2016;7(75):72-79. (In Russ.).
  22. Savlevich EL, Doroshchenko NE, Slavinskaya IS, Farikov SE. Important factors of the inflammatory process in the o ropharynx and optimal treatment regimes selection. Medical Council. 2017;16:48-54. (In Russ.). https://doi.org/10.21518/2079-701X-2017-16-48-54
  23. Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology. 1998;6(2):95-107.  https://doi.org/10.1007/s10787-998-0026-0
  24. Lang DH, Rettie AE. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. British Journal of Clinical Pharmacology. 2000;50(4):311-314.  https://doi.org/10.1046/j.1365-2125.2000.00265.x
  25. Denisenko RYu. Experience of using the drug Tantum Verde in the postoperative treatment of patients after tonsillectomy. Novosti meditsiny i farmatsii. 2013;17(471):9. (In Russ.).
  26. Schachtel BP, Padjarino DA. Randomized, double-blind, placebo-controlled model demonstrating a local effect of benzydamine in children with tonsillopharyngitis. Zdorov’e rebenka. 2012;8(43): 73-76. (In Russ.).
  27. Whiteside MW. A controlled study of benzydamine oral rinse (‘Difflam’) in general practice. Current Medical Research and Opinion. 1982;8(3):188-190.  https://doi.org/10.1185/03007998209112381
  28. Shakespeare V, Shakespeare PG, Evans BT. Effects of proprietary oral rinses containing chlorhexidine, hexetidine and benzydamine on the proliferation of human buccal epithelial cells in culture. Archives of Oral Biology. 1988;33(12):881-885.  https://doi.org/10.1016/0003-9969(88)90017-9
  29. Mynbaev OA, Eliseeva MYu, Masikhi KN, Manukhin IB, Tsarev VN. Groprinosin is a highly effective immunostimulant for ‘difficult’ patients with impaired immune system. Trudny’j patsient. 2009;7(8-9):5-12. (In Russ.).
  30. Isakov VA, Belyaeva TV, Afanas’eva OI. Optimization of anti-viral therapy of influenza in children and adults. Current Pediatrics. 2013;12(1):136-140. (In Russ.). https://doi.org/10.15690/vsp.v12i1.570
  31. Simovanyan EN, Denisenko VB, Grigoryan AV. The Effectiveness of Complex Use of Inosine Pranobex and Recombinant Interferon-α2b by Chronic Epstein-Barr Virus Infection in Frequently Ill Children. Detskie infektsii. 2015;14(4):31-45. (In Russ.). https://doi.org/10.22627/2072-8107-2015-14-4-31-45
  32. Savinova OV, Boreko EI, Amvrosyeva TV, Kishkurno EP. Protivovirusnoe dejstvie groprinosina v otnoshenii enterovirusa ECHO 6. Accessed August 06, 2021. (In Russ.). https://med.by/dmn/book.php?book=07-34_4
  33. Mikhailova EV, Levin DYu, Serdyukov AYu. The effectiveness of antiviral therapy in combined forms of enterovirus infection in children. Voprosy prakticheskoj pediatrii. 2017;12(6):77-80. (In Russ). https://doi.org/10.20953/1817-7646-2017-6-77-80
  34. Petrova M, Jelev D, Ivanova A, Krastev Z. Isoprinosine affects serum cytokine levels in healthy adults. Journal of Interferon and Cytokine Research. 2010;30(4):223-228.  https://doi.org/10.1089/jir.2009.0057
  35. Tobólska S, Terpiłowska S, Jaroszewski J, Siwicki AK. Genotoxicity and Mutagenicity of Inosine Pranobex. Journal of Veterinary Research. 2018;62(2):207-213.  https://doi.org/10.2478/jvetres-2018-0030

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.